X0306 4 2018-02-28 false 0001517022 Akebia Therapeutics, Inc. AKBA 0001669737 Dahan Michel C/O AKEBIA THERAPEUTICS, INC. 245 FIRST STREET CAMBRIDGE MA 02142 false true false false SVP, Chief Business Officer Common Stock 2018-02-28 4 A false 19400.00 0.00 A 115226.00 D Employee Stock Option (Right to buy) 14.30 2018-02-28 4 A false 27500.00 0.00 A 2028-02-28 Common Stock 27500.00 27500.00 D The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan. One hundred percent of the restricted stock units will vest on the third anniversary of the grant date. The options were granted by the Issuer pursuant to its 2014 Incentive Plan. 25% of the shares underlying this option will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter. Nicole R. Hadas, attorney-in-fact for Michel Dahan 2018-03-02